Pentavalent vaccine, Pediarix, DTaP-Hep B-IPV vaccine
Showing 51 - 75 of >10,000
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders
Completed
- HIV Infections
- +2 more
-
Baltimore, Maryland
- +1 more
Mar 17, 2023
Splenectomy; Status Trial (Bexsero)
Not yet recruiting
- Splenectomy; Status
- Bexsero
- (no location specified)
Aug 29, 2023
Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)
Not yet recruiting
- Chronic Hepatitis b
- ISA104
- Placebo
-
Rotterdam, NetherlandsErasmus MC
Apr 21, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023
SARS-CoV2 COVID-19 Trial in Randwick, Adelaide, Perth (COVIGEN C19 0.8 mg ID or Placebo ID, COVIGEN C19 2.0 mg IM or Placebo IM,
Active, not recruiting
- SARS-CoV2 COVID-19
- COVIGEN C19 0.8 mg ID or Placebo ID
- +3 more
-
Randwick, New South Wales, Australia
- +2 more
Nov 17, 2022
Meningococcal Immunisation Trial in Puerto Rico, United States (Multicomponent Meningococcal B Vaccine, Meningococcal Group B
Recruiting
- Meningococcal Immunisation
- Multicomponent Meningococcal B Vaccine
- +4 more
-
Guntersville, Alabama
- +21 more
Jan 30, 2023
HIV Infection, Hepatitis B Trial in Worldwide (HEPLISAV-B, ENGERIX-B)
Recruiting
- HIV Infection
- Hepatitis B
- HEPLISAV-B
- ENGERIX-B
-
Birmingham, Alabama
- +47 more
Dec 13, 2022
Lymphoma Trial in Houston (PCV20)
Not yet recruiting
- Lymphoma
- PCV20
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2023
Hepatitis B Trial in Hanoi (Sci-B-Vac-Lot B, Sci-B-Vac-Lot A, Engerix-B)
Completed
- Hepatitis B
- Sci-B-Vac-Lot B
- +2 more
-
Hanoi, VietnamNational Institute of Hygiene and Epidemiology (NIHE)
Jul 18, 2022
Poliomyelitis, Vaccine Reaction Trial (Eupolio)
Not yet recruiting
- Poliomyelitis
- Vaccine Reaction
- Eupolio
- (no location specified)
Jun 23, 2022
Enterovirus Infections, Influenza Trial in Hangzhou (EV71 vaccine and influenza vaccine, EV71 vaccine, influenza vaccine)
Completed
- Enterovirus Infections
- Influenza
- EV71 vaccine and influenza vaccine
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang provincial center for disease control and prevention
Oct 10, 2022
Healthy Trial in Cuangugu, Gysenyi, Kigali (Ad26.ZEBOV, MVA-BN-Filo)
Active, not recruiting
- Healthy
- Ad26.ZEBOV
- MVA-BN-Filo
-
Cuangugu, Rwanda
- +2 more
Jan 17, 2023
Covid19 Trial in Australia (SII B.1.351, SII Bivalent, SII B.1.617.2)
Withdrawn
- Covid19
- SII B.1.351
- +2 more
-
Maroubra, New South Wales, Australia
- +3 more
May 25, 2022
Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)
Not yet recruiting
- Iron Deficiency Anemia
- Iron-fortified cookies
- +3 more
- (no location specified)
Aug 30, 2023
Hepatitis B Trial (Modified Process Hepatitis B Vaccine)
Completed
- Hepatitis B
- Modified Process Hepatitis B Vaccine
- (no location specified)
Aug 19, 2022
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women
Not yet recruiting
- HPV Infection
- +2 more
- Follow up
-
Fuzhou, Fujian, ChinaFujian Maternity and Child Health Hospital
Nov 16, 2023
Infant, Newborn, Pain Trial in Yakutiye (Palmar grasp reflex)
Recruiting
- Infant, Newborn, Pain
- Palmar grasp reflex
-
Yakutiye, Erzurum, TurkeyTürkan Kadiroğlu
Jan 3, 2023
Shingles, Herpes Zoster Infection, Human Trial (Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection,
Not yet recruiting
- Shingles
- +2 more
- Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection
- +6 more
- (no location specified)
Jan 19, 2023
Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)
Not yet recruiting
- Ovarian Carcinoma
- PEP-DC1
- +3 more
- (no location specified)
Jan 26, 2023
Whooping Cough, Diphtheria, Tetanus Trial in China (Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined
Recruiting
- Whooping Cough
- +2 more
- Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
- +2 more
-
Anyang, Henan, China
- +3 more
Oct 26, 2021
COVID-19 Trial in United States (Vaccine Messaging, Vaccine Acceptance Question)
Not yet recruiting
- COVID-19
- Vaccine Messaging
- Vaccine Acceptance Question
-
San Francisco, California
- +6 more
Dec 1, 2023